Clover Health Investments
CLOVClover Health is a technology-centric healthcare company that operates Medicare Advantage plans and develops proprietary software to improve clinical decision-making.
Earnings
Next report
Nov 4, 2026 (In 3 days)Financials
Q2 2026Valuation & ratios
Segments
By segment
Competitors
By market cap
By revenue growth
By net margin
Profile
Clover Health is a technology-centric healthcare company that operates Medicare Advantage plans and develops proprietary software to improve clinical decision-making. The company's core value proposition centers on its AI-powered platform, which provides physicians with real-time, data-driven insights to identify and manage chronic diseases earlier. By integrating insurance operations with advanced software, the company aims to reduce medical expenses and improve health outcomes for the Medicare-eligible population.
Clover Health positions itself as a tech-first disruptor in the Medicare Advantage space, utilizing a proprietary AI feedback loop to outperform traditional managed care plans.
FAQ
- What is Clover Health Investments's market cap?
- Clover Health Investments (CLOV) has a market capitalization of $2.4B and trades on NASDAQ.
- What is Clover Health Investments's revenue and profitability?
- Clover Health Investments generated $2.5B in trailing twelve-month revenue with a net loss of $18.4M, representing a net margin of -0.7%, with free cash flow of $74.2M. The latest reported period is Q2 2026.
- Who are Clover Health Investments's competitors?
- Clover Health Investments's key competitors include Alignment Healthcare, Humana, UnitedHealth Group, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Clover Health Investments have?
- Clover Health Investments's subsidiaries include Counterpart Health, Inc..
- Where is Clover Health Investments headquartered?
- Clover Health Investments is headquartered in United States of America and employs approximately 552 people. It has been publicly traded since 2021.
